Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | AJCC TNM Post Therapy Path (yp) Stage Group (AJCC8TNMPostTxStgGrp) | 33167 | Yes |
AJCC | AJCC TNM Post Therapy Path (yp) Stage Group | Yes |
Field length: 15
This field will be used for cases 01/01/2018 and forward.
Description
Detailed site-specific codes for the postneoadjuvant therapy stage group as defined by AJCC 8th edition.
Rationale
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Identifies the remaining anatomic extent of disease based on the T and N following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and planned postneoadjuvant therapy surgical resection, and the M status defined during the diagnostic workup.
Codes (in addition to those published in the AJCC 8th edition Cancer Staging Manual)
| Code | Description |
|---|---|
| 88 | Not applicable, no code assigned for this case in the current AJCC 8th edition Staging Manual. |
| 99 | Unknown, not staged |
Note: See the AJCC 8th edition Cancer Staging Manual for site-specific categories for the TNM categories and stage groups. See the CURRENT STORE manual for specifications for codes and data entry rules.
Overview
Content Tools
Activity